tiprankstipranks
Ginkgo Bioworks Holdings (DNA)
NYSE:DNA
US Market

Ginkgo Bioworks Holdings Stock Price & Analysis

501 Followers

DNA Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$2.09 - $15.86
Previous Close$2.8
Volume6.31M
Average Volume (3M)24.45M
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)$1.38B
Total Debt (Recent Filing)$17.02M
P/E Ratio-1.5
Beta2.02
Next EarningsNov 14, 2022
Next Dividend Ex-DateN/A
Dividend YieldN/A
EPS (TTM)-1.84
Shares Outstanding1,875,320,626
R-Squared0.48
Standard Deviation0.19
10 Day Avg. Volume24,642,892
30 Day Avg. Volume24,450,960
P/B Ratio3.58
P/S Ratio6.19
P/CF RatioN/A
P/FCF Ratio-14.90
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/EbitdaN/A
Price Target Upside291.68% Upside
Rating ConsensusStrong Buy
Alpha-0.09
Number of Analyst Covering4


Financials

Yearly

P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

---

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.

---

DNA FAQ

What was Ginkgo Bioworks Holdings’s price range in the past 12 months?
Ginkgo Bioworks Holdings lowest stock price was $2.09 and its highest was $15.86 in the past 12 months.
    What is Ginkgo Bioworks Holdings’s market cap?
    Currently, no data Available
    When is Ginkgo Bioworks Holdings’s upcoming earnings report date?
    Ginkgo Bioworks Holdings’s upcoming earnings report date is Nov 14, 2022 which is in 49 days.
      How were Ginkgo Bioworks Holdings’s earnings last quarter?
      Ginkgo Bioworks Holdings released its earnings results on Aug 15, 2022. The company reported -$0.41 earnings per share for the quarter, missing the consensus estimate of -$0.043 by -$0.367.
        Is Ginkgo Bioworks Holdings overvalued?
        According to Wall Street analysts Ginkgo Bioworks Holdings’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Ginkgo Bioworks Holdings pay dividends?
          Ginkgo Bioworks Holdings does not currently pay dividends.
          What is Ginkgo Bioworks Holdings’s EPS estimate?
          Ginkgo Bioworks Holdings’s EPS estimate is -$0.28.
            How many shares outstanding does Ginkgo Bioworks Holdings have?
            Ginkgo Bioworks Holdings has 1,191,989,400 shares outstanding.
              What happened to Ginkgo Bioworks Holdings’s price movement after its last earnings report?
              Ginkgo Bioworks Holdings reported an EPS of -$0.41 in its last earnings report, missing expectations of -$0.043. Following the earnings report the stock price went up 7.163%.
                Which hedge fund is a major shareholder of Ginkgo Bioworks Holdings?
                Among the largest hedge funds holding Ginkgo Bioworks Holdings’s share is ARK Investment Management LLC. It holds Ginkgo Bioworks Holdings’s shares valued at 208M.

                  ---

                  Ginkgo Bioworks Holdings Stock Analysis

                  Smart ScoreNeutral
                  1
                  2
                  3
                  4
                  5
                  6
                  7
                  8
                  9
                  10
                  7
                  The Ginkgo Bioworks Holdings stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Ginkgo Bioworks Holdings

                  Ginkgo Bioworks Holdings (NYSE:DNA) is a biotechnology company that offers a platform for cell programming that enables the biological production of various products across the food, pharmaceutical, and fragrance industry. Its platform provides equipment, software, robotic automation, and tools to support genetic engineering, analytics, and fermentation.

                  ---
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Sherwin-Williams Company
                  Ecolab
                  International Flavors & Fragrances
                  PPG Industries
                  DuPont de Nemours

                  Popular Stocks

                  ---
                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis